Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Just Published

Just published : Multiple sclerosis: new study points to 5 warning signs

Just published  Sclérose en plaques  une nouvelle étude pointe 5 signes avant-coureurs

What if the biological mechanisms causing multiple sclerosis were triggered years before clinical diagnosis? This is what a team at Paris Brain Institute suggests in a new study published in the journal Neurology. By analyzing the health data of several tens of thousands of patients, researchers show that the disease sets in with discrete signs several years before the onset of classic symptoms.

News that might interest you

Neurone de la rétine prolongé par un long axone entouré de sa gaine de myéline. Crédit : Annie Cavanagh, Wellcome collection.
Early cortical remyelination has a neuroprotective effect in multiple sclerosis
Multiple sclerosis is a heterogeneous disease whose manifestations vary considerably from patient to patient and whose course appears, on the surface, unpredictable. Hence, it is crucial to identify the factors that drive disability progression. In a...
04.02.2024 Research, science & health
sclérose en plaques
Multiple sclerosis: new study highlights five warning signs of the disease
What if the biological mechanisms that cause multiple sclerosis were triggered years before clinical diagnosis? This is what a team at Paris Brain Institute suggests in a new study published in Neurology. The researchers show that, on a population...
12.06.2023 Research, science & health
Têtard de Xénope transgénique chez lequel la substance blanche (myéline) apparaît par fluorescence, en vert. Crédit : David Akbar (plateforme ICM Quant) et Elodie Martin (Equipe Lubetzki/Stankoff).
Multiple sclerosis: a new tool to reduce clinical failure
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules...
03.03.2023 Research, science & health
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
In an article recently published in the European Journal of Neurology, Vito Ricigliano (AP-HP), Benedetta Bodini (AP-HP/Sorbonne University) and their collaborators at the Paris Brain Institute, demonstrate the protective effect of myelin repair on...
02.24.2022 Research, science & health
image
New data on inflammation in multiple sclerosis using PET-MRI
Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of...
10.20.2021 Research, science & health
Sclérose en plaques et COVID-19
Multiple sclerosis and covid-19
DOES MULTIPLE SCLEROSIS (MS) ALTER THE RISK OF DEVELOPING A SEVERE FORM OF COVID-19 INFECTION? WHAT ARE THE CLINICAL FEATURES AND EFFECTS OF CORONAVIRUS INFECTION IN PATIENTS WITH MS? DO SPECIFIC TREATMENTS FOR SEPSIS INCREASE OR DECREASE THE...
07.08.2020 Research, science & health
See all our news